131 related articles for article (PubMed ID: 1377406)
21. Transplantation of CD34+ hematopoietic precursors: clinical rationale.
Berenson RJ
Transplant Proc; 1992 Dec; 24(6):3032-4. PubMed ID: 1281584
[No Abstract] [Full Text] [Related]
22. Automated processing of human vertebral body bone marrow yields preparations with stem cell content similar to that obtained with traditional manual preparation.
Kenyon NS; Xu XM; Knapp J; Selvaggi GS; Bottino R; Kong SS; Qian T; Linetsky E; Ricordi C
Transplant Proc; 1995 Dec; 27(6):3418. PubMed ID: 8540030
[No Abstract] [Full Text] [Related]
23. A technique for isolation of bone marrow cells using hydroxyethyl starch (HES) sedimentation agent.
Montuoro A; De Rosa L; Del Monte C; Blandino F; Pandolfi A; Lanti T; De Laurenzi A
Haematologica; 1991 Mar; 76 Suppl 1():7-9. PubMed ID: 1713876
[TBL] [Abstract][Full Text] [Related]
24. The AIS CELLector: a new technology for stem cell purification.
Okarma T; Lebkowski J; Schain L; Harvey M; Tricot G; Srour E; Meyers WG; Burnett A; Sniecinski I; O'Reilly RJ
Prog Clin Biol Res; 1992; 377():487-502; discussion 503-4. PubMed ID: 1279717
[No Abstract] [Full Text] [Related]
25. Evaluation of the Ceprate LC34 affinity system for the enrichment of CD34+ hematopoietic stem cells from cord blood.
Kögler G; Somville T; Werner P
Blood Cells; 1994; 20(2-3):371-5. PubMed ID: 7538341
[TBL] [Abstract][Full Text] [Related]
26. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
[TBL] [Abstract][Full Text] [Related]
27. Peripheral blood stem cell transplantation: from laboratory to clinical practice.
Mangan KF
Semin Oncol; 1995 Jun; 22(3):202-9. PubMed ID: 7539938
[No Abstract] [Full Text] [Related]
28. Processing of bone marrow for transplantation: development of a mononuclear cell enrichment protocol.
Hollingsworth KL; Williams SF; Blake MS; Pothiawala M; Mick R; Larson RA; Bender JG
Prog Clin Biol Res; 1994; 389():695-704. PubMed ID: 7700937
[No Abstract] [Full Text] [Related]
29. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR
Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
[TBL] [Abstract][Full Text] [Related]
30. CD34+ selected cells in clinical transplantation.
Collins RH
Stem Cells; 1994 Nov; 12(6):577-85. PubMed ID: 7533577
[TBL] [Abstract][Full Text] [Related]
31. Pre-clinical evaluation of anti-lacto-N-fucopentaose III (CD15) monoclonal antibodies for ex vivo bone marrow purging in acute myeloid leukemia.
Guyotat D; Shi ZH; Campos L; Rabat M; Bonnier S; Poncelet P; Laurent JC; Fiere D
Bone Marrow Transplant; 1990 Dec; 6(6):385-90. PubMed ID: 1982926
[TBL] [Abstract][Full Text] [Related]
32. CD34 or S313 positive cells selection by avidin-biotin immunoadsorption.
Tassi C; Fortuna A; Bontadini A; Lemoli RM; Gobbi M; Tazzari PL
Haematologica; 1991 Mar; 76 Suppl 1():41-3. PubMed ID: 1713873
[TBL] [Abstract][Full Text] [Related]
33. Quality assurance in flow cytometry: comparison of three analytical methods for quantifying CD34+ cells in marrow.
Yu M; Cottler-Fox M
Prog Clin Biol Res; 1994; 389():729-36. PubMed ID: 7535464
[No Abstract] [Full Text] [Related]
34. CD34+ progenitor cell isolation from blood and marrow: a comparison of techniques for small-scale selection.
Winslow JM; Liesveld JL; Ryan DH; Dipersio JF; Abboud CN
Bone Marrow Transplant; 1994 Aug; 14(2):265-71. PubMed ID: 7527686
[TBL] [Abstract][Full Text] [Related]
35. Purging and haemopoietic progenitor cell selection by CD34+ cell separation.
Krüger W; Gruber M; Hennings S; Fehse N; Fehse B; Gutensohn K; Kröger N; Zander AR
Bone Marrow Transplant; 1998 Apr; 21(7):665-71. PubMed ID: 9578305
[TBL] [Abstract][Full Text] [Related]
36. Mature human hematopoietic cells in donor bone marrow complicate interpretation of stem/progenitor cell assays in xenogeneic hematopoietic chimeras.
Ramírez M; Rottman GA; Shultz LD; Civin CI
Exp Hematol; 1998 Apr; 26(4):332-44. PubMed ID: 9546317
[TBL] [Abstract][Full Text] [Related]
37. Isolation of primitive hematopoietic stem cells.
Wagner JE
Semin Hematol; 1992 Apr; 29(2 Suppl 1):6-9. PubMed ID: 1377405
[No Abstract] [Full Text] [Related]
38. Analysis of human hematopoietic stem cell populations.
Murray L; DiGiusto D; Chen B; Chen S; Combs J; Conti A; Galy A; Negrin R; Tricot G; Tsukamoto A
Blood Cells; 1994; 20(2-3):364-9; discussion 369-70. PubMed ID: 7538340
[TBL] [Abstract][Full Text] [Related]
39. A comparison of CD34+ cell selected and unselected autologous peripheral blood stem cell transplantation for multiple myeloma: a case controlled analysis.
Gandhi M; Jestice H; Scott M; Bloxham D; Bass G; Craig J; Marcus R
Bone Marrow Transplant; 1999 Aug; 24(4):369-75. PubMed ID: 10467325
[TBL] [Abstract][Full Text] [Related]
40. Comparative assays of megakaryocyte progenitors in CD34+ peripheral blood progenitor cell fractions.
Petsche D; Hami L; Purdy M; Myers S; Hogan C; Messner H; Briddell R; Heimfeld S; Berenson R; Shpall E
Prog Clin Biol Res; 1994; 389():415-20. PubMed ID: 7535450
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
